A resolution designating September 25, 2025, as "National Ataxia Awareness Day", and raising awareness of ataxia, ataxia research, and the search for a cure. | ChamberLight
A resolution designating September 25, 2025, as "National Ataxia Awareness Day", and raising awareness of ataxia, ataxia research, and the search for a cure.
INTRO OCT 9· LAST ACTION OCT 9
READING
3MIN
COSPONSORS
2BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Non-binding
LEGISLATIVE PROGRESS
STEP 4 / 8
Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
Voters should care about this bill because it brings national attention to a rare and often debilitating neurological disorder that affects thousands of Americans, including children. By designating a specific day for awareness, it aims to shine a spotlight on a condition that may not receive widespread public understanding or research funding.
If this resolution becomes law, it could lead to increased public and professional awareness, potentially improving early diagnosis and access to support services for patients. It also signals governmental recognition of the need for accelerated research into treatments and a cure, which could ultimately improve the quality of life for those affected. If it doesn't become law, the opportunity for this specific national awareness day and the associated public focus would be missed.
KEY PROVISIONS
5AI-extracted
PROVISION 01
Designates September 25, 2025, as "National Ataxia Awareness Day."
This formal designation creates a specific annual focus for public attention on ataxia.
PROVISION 02
Recognizes the need for greater public awareness of ataxia, its causes, and symptoms.
Increased public understanding can help reduce stigma, improve early recognition, and foster empathy for affected individuals.
PROVISION 03
Supports improved diagnosis of ataxia and access to care for patients.
Better diagnosis and care access are crucial for managing the disease and improving patient outcomes.
PROVISION 04
Encourages the acceleration of ataxia research, including for effective treatments and a cure.
Ongoing research is essential for finding new therapies and ultimately eradicating the disease.
PROVISION 05
Acknowledges the individuals in the United States who face challenges due to ataxia, and their families.
This provision offers recognition and support to those directly impacted by the condition.
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
FLOOR
OCT 9
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S7101; text: CR S7097)
A resolution designating September 25, 2025, as "National Ataxia Awareness Day", and raising awareness of ataxia, ataxia research, and the search for a cure.
Voters should care about this bill because it brings national attention to a rare and often debilitating neurological disorder that affects thousands of Americans, including children. By designating a specific day for awareness, it aims to shine a spotlight on a condition that may not receive widespread public understanding or research funding.
If this resolution becomes law, it could lead to increased public and professional awareness, potentially improving early diagnosis and access to support services for patients. It also signals governmental recognition of the need for accelerated research into treatments and a cure, which could ultimately improve the quality of life for those affected. If it doesn't become law, the opportunity for this specific national awareness day and the associated public focus would be missed.
KEY PROVISIONS
AI-extracted
high
Designates September 25, 2025, as "National Ataxia Awareness Day."
This formal designation creates a specific annual focus for public attention on ataxia.
med
Recognizes the need for greater public awareness of ataxia, its causes, and symptoms.
Increased public understanding can help reduce stigma, improve early recognition, and foster empathy for affected individuals.
high
Supports improved diagnosis of ataxia and access to care for patients.
Better diagnosis and care access are crucial for managing the disease and improving patient outcomes.
high
Encourages the acceleration of ataxia research, including for effective treatments and a cure.
Ongoing research is essential for finding new therapies and ultimately eradicating the disease.
low
Acknowledges the individuals in the United States who face challenges due to ataxia, and their families.
This provision offers recognition and support to those directly impacted by the condition.
A neurological symptom indicating problems with the brain that affect coordination, precision, and timing of physical movements.
Neurodegenerative diseases
Diseases that involve the progressive loss of brain or nerve cells over time.
Orphan Drug Act
A federal law designed to encourage the development of drugs for rare diseases by providing incentives to pharmaceutical companies.
Autosomal dominant/recessive
Terms describing how certain genetic traits or diseases are passed down from parents to children. Dominant means only one copy of a gene is needed, recessive means two copies are needed.
Resolution
A formal statement or expression of opinion by a legislative body, like the Senate, that does not become a public law.
Cardiomyopathy
A disease of the heart muscle that makes it harder for the heart to pump blood to the rest of the body.
Scoliosis
A sideways curvature of the spine.
ACTION TIMELINE
3 EVENTS
OCT 9, 25
Introduced in Senate
INTROREFERRAL
OCT 9, 25
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
FLOOR
OCT 9, 25
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S7101; text: CR S7097)